Sign in to view content

Endophthalmitis After Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Inhibitors: Management and Visual Outcomes

Kunyong Xu, MD, MHSc

Video
Published 2018

Related

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Gene Expression Modifications in Anti-VEGF Treated Retinal Müller Cells
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2016
Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2018

Category: Inflammatory and Infectious Diseases

See more